MCOV B Stock Overview
Provides healthcare and diagnostic services in Poland, Sweden, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Medicover AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 192.40 |
| 52 Week High | SEK 206.50 |
| 52 Week Low | SEK 129.20 |
| Beta | 1.46 |
| 1 Month Change | 8.95% |
| 3 Month Change | 0.10% |
| 1 Year Change | 27.93% |
| 3 Year Change | -41.96% |
| 5 Year Change | 81.51% |
| Change since IPO | 193.74% |
Recent News & Updates
Medicover AB (publ)'s (STO:MCOV B) Popularity With Investors Is Clear
Dec 12
The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business
Nov 07Recent updates
Medicover AB (publ)'s (STO:MCOV B) Popularity With Investors Is Clear
Dec 12The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business
Nov 07Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return
Oct 24Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects
Apr 22Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings
Apr 04Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet
Mar 05Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price
Feb 11Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture
Dec 20Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?
Dec 02Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business
Sep 12Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet
Aug 21Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?
Jun 12Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends
May 27Is Medicover (STO:MCOV B) Using Too Much Debt?
May 12Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes
Feb 16Is Medicover (STO:MCOV B) Using Too Much Debt?
Jan 30Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?
Dec 30Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)
Dec 17Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger
Oct 30Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?
Oct 16Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now?
Sep 09Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B)
Jul 25Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet
Jul 12Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B)
Jun 13At kr179, Is It Time To Put Medicover AB (publ) (STO:MCOV B) On Your Watch List?
May 29Shareholder Returns
| MCOV B | SE Healthcare | SE Market | |
|---|---|---|---|
| 7D | 3.7% | 1.0% | -2.7% |
| 1Y | 27.9% | 36.4% | 4.6% |
Return vs Industry: MCOV B underperformed the Swedish Healthcare industry which returned 36.4% over the past year.
Return vs Market: MCOV B exceeded the Swedish Market which returned 4.6% over the past year.
Price Volatility
| MCOV B volatility | |
|---|---|
| MCOV B Average Weekly Movement | 4.2% |
| Healthcare Industry Average Movement | 4.3% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.3% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: MCOV B has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: MCOV B's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 45,000 | Fredrik Rågmark | www.medicover.com |
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company’s Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. Its Diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology.
Medicover AB (publ) Fundamentals Summary
| MCOV B fundamental statistics | |
|---|---|
| Market cap | SEK 28.89b |
| Earnings (TTM) | SEK 226.65m |
| Revenue (TTM) | SEK 22.99b |
127.4x
P/E Ratio1.3x
P/S RatioIs MCOV B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MCOV B income statement (TTM) | |
|---|---|
| Revenue | €2.00b |
| Cost of Revenue | €1.58b |
| Gross Profit | €413.60m |
| Other Expenses | €393.90m |
| Earnings | €19.70m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 12, 2025
| Earnings per share (EPS) | 0.13 |
| Gross Margin | 20.70% |
| Net Profit Margin | 0.99% |
| Debt/Equity Ratio | 121.9% |
How did MCOV B perform over the long term?
See historical performance and comparisonDividends
0.7%
Current Dividend Yield91%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 03:00 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medicover AB (publ) is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |
| Lars Hevreng | Danske Bank |
| James Alexander Vane-Tempest | Jefferies LLC |